Nauclea latifolia stem-bark extract protects the prefrontal cortex from valproic acid - induced oxidative stress in rats: Effect on B-cell lymphoma and neuron specific enolase protein expression
DOI:
https://doi.org/10.30574/gscbps.2019.7.1.0067Keywords:
Nauclea latifolia stem-bark, Valproic acid–induced neurotoxicity, Oxidative stress, Prefrontal cortex, Neuron specific enolase, ImmunohistochemistryAbstract
Nauclea latifolia stem-bark (NLS) is widely utilized for broad spectrum pathologies. The study evaluated the protective effects of NLS extract supplemented along with valproic acid on oxidative stress markers, and neuron specific enolase (NSE) and B cell lymphoma 2 (bcl-2) protein expressions in prefrontal cortex of rats. The NLS extract was administered in three doses (50, 100, 200mg/kg) after pre-treatment of the experimental animals with high dose valproic acid (VPA) (500 mg/kg) orally daily by subacute exposure for 28 days. The rats were sacrificed and the prefrontal cortex (PFC) of the brain abstracted and homogenized in ice for biochemical assays to estimate the levels oxidative stress markers; histopathological examination to reveal the histomorphorgical changes and immunohistochemistry to examine effect on NSE andbcl-2protein expressions. The findings revealed significant (P < 0.05 – 0.001) elevation of oxidative stress induced by VPA. The NLS extract supplementation mediate significant elevation of the levels of reduced glutathione (P< 0.05 – 0.01), antioxidant enzymes [glutathione peroxidase (P< 0.001), superoxide dismutase (P < 0.001), catalase (P< 0.05 – 0.01) and glutathione-s-transferase (P < 0.05 – 0.01)] and significant decline of lipid peroxidation marker, malondialdehyde, (NLS group vs diseases control group (P < 0.001). The NLS extract studied down-regulated NSE at the prefrontal cortex preventing neuronal damage but no effect on bcl-2 protein expression. We conclude that NLS extract has potential to mitigate VPA induced neurotoxicity by obliterating oxidative stress and down regulating NSE expression, effects demonstrating probable therapeutic role in neurodegenerative diseases.
Metrics
References
Miller EK and Cohen JD. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167–202.
Arnsten AF. (2009). Stress signaling pathways that impair prefrontal cortex structure and function. Nature Review Neuroscience, 10, 410 - 422.
Chang YT, Chang WN, Tsai NW, Huang CC, Kung CT, SuYJ, Lin WC, Cheng BC, Su CM, Chiang YF and Lu CH. (2014). The roles of biomarkers of oxidative stress and antioxidant in Alzheimer’s disease: A Systematic Review. Bio Med Research International, 2014, 1–14.
Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW and Feng Y. (2015). The role of oxidative stress and antioxidants in liver diseases. International Journal of Molecular Sciences, 16(11), 26087–26124.
Uttara B, Singh A, Zamboni P and Mahajan R. (2009). Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology, 7(1), 65–74.
Adly AA. (2010). Oxidative stress and disease: An updated review. Research Journal of Immunology, 3(2), 129–145.
Gueetens G, Boeck GD, Highley M, Oosterom ATV and Bruijn EAD. (2002). Oxidative DNA damage: Biological significance and methods of analysis. Critical Reviews in Clinical Laboratory Sciences, 39(4-5), 331–457.
Shim SY and Kim HS. (2013). Oxidative stress and the antioxidant enzyme system in the developing brain. Korean Journal of Pediatrics, 56(3), 107
Villegas L. (2014). Oxidative stress and therapeutic development in lung diseases. Journal of Pulmonary and Respiratory Medicine, 04(04).
Jain KK. (2011). Neuroprotective Agents. The Handbook of Neuroprotection. New York: Humana/Springer, 25–139
Cheung F, Wang X, Wang N, Yuen MF, Ziea TC, Tong Y, Wong V T and Feng Y. (2013). Chinese medicines as an adjuvant therapy for unresectable hepatocellular carcinoma during trans-arterial chemoembolization: A meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine, 1–25.
Wang N and Feng Y. (2015). Elaborating the role of natural products-induced autophagy in cancer treatment: achievements and artifacts in the state of the art. BioMedicine Research International, 2015, 1–14.
Vašková J., Vaško, L. and M., Kron, I. (2012). Oxidative processes and antioxidative metaloenzymes. In: Mohammed Amr El-Missiry, ed., Antioxidant Enzyme. 1st ed. Rijeka, Croatia: IntechOpen, 19-58.
Gilgun-Sherki Y, Melamed E and Offen D. (2001). Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology, 40(8), 959–975.
Krishnamurthy P and Wadhwani A. (2012). Antioxidant Enzymes and Human Health. In: Mohammed Amr El-Missiry, ed., Antioxidant Enzyme. 1st ed. Rijeka, Croatia: IntechOpen, 3-18.
Pejić S, Stojiljković V, Todorović A, Gavrilović L, Pavlović I, Popović N and Pajović SB. (2016). Antioxidant enzymes in brain cortex of rats exposed to acute, chronic and combined stress. Folia Biologica, 64(3), 189–195.
Fang YZ, Yang S and Wu G. (2002). Free radicals, antioxidants, and nutrition. Nutrition, 18(10), 872–879.
Shamseer L, Adams D, Brown N, Johnson J A and Vohra S. (2010). Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews.
Konrath EL, Neves BM, Lunardi PS, Passos CDS, Simões-Pires A, Ortega MG, Gonçalves CA, Cabrera JL, Moreira JCF and Henriques AT. (2012). Investigation of the in vitro and ex vivo acetylcholinesterase and antioxidant activities of traditionally used Lycopodium species from South America on alkaloid extracts. Journal of Ethnopharmacology, 139(1), 58–67.
Chateauvieux S, Morceau F, Dicato M. and Diederich, M. (2010). Molecular and therapeutic potential and toxicity of valproic acid. Journal Biomedicine and Biotechnolog, (2010).
Rosenberg G. (2007). The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cellular and Molecular Life Sciences, 64(16), 2090–2103.
Ximenes JCM, Verde ECL, Naffah-Mazzacoratti MDG and Viana GSDB. (2012). Valproic acid, a drug with multiple molecular targets related to its potential neuroprotective action. Neuroscience and Medicine, 03(01), 107–123.
Mark RJ, Ashford JW, Goodman Y and Mattson MP. (1995). Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology. Neurobiology Aging, 16 (1995), 187–198.
Hashimoto R, Hough C, Nakazawa T, Yamamoto T and Chuang DM. (2002). Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. Journal Neurochemistry, 80 (2002), 589 –597.
Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS and Chuang DM. (2003). Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Letters. 542 (2003): 74–78.
Lahneche AM, Boucheham R, Boubekri N, Bensaci S, Bicha S, Bentamenne A, Bentamenne FB, Benayache S and Zama D. (2017). Sodium Valproate-Induced Hepatic Dysfunction in Albino Rats and Protective Role of n-Butanol Extract of Centaurea sphaerocephala L. International Journal of Pharmacognosy and Phytochemical Research, 9(10), 1335-1343.
Ben-Cherif W, Dridi I, Hassine M, Ben-Attia M, Aouam K, Reinberg A and Boughattas N. (2014). Circadian haematotoxicity of the antiepileptic valproic acid in mice. Journal of Applied Biomedicine, 12(1), 31–38.
Ikechukwu UR, Nwadiogbu OV, Ikechukwu ES and Obiora A. (2017). Hepatoprotective and Healthy Kidney Promoting Potentials of Methanol Extract of Nauclea latifolia in Alloxan Induced Diabetic Male Wistar Albino Rats. Asian Journal of Biochemistry, 12(3), 71–78.
Morsy BM, Safwat GM, Hussein DA and Samy RM. (2017). The protective effect of Nigella sativa oil extract against neurotoxicity induced by Valproic acid. International Journal of Bioassays, 6(9), 5474.
Lloyd KA. (2013). A scientific review: mechanisms of valproate-mediated teratogenesis. Bioscience Horizons, 6.
Mageid AD, Al-Komi AA and Wadoud IMA. (2015). Biochemical effect of l-Carnitine in Valporate induced hyperammonemia in rabbits. Benha Veterinary Medicine, 27(2), 97-208.
Segurna-Bruna N, Rodriguez-Campello A, Puente V and Roquer J. (2006). Valproate-induced hyperammonemic encephalopathy. Acta Neurologica Scandinavica, 114(1), 1–7.
Mock CM and Schwetschenau KH. (2011). Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. American Journal of Health-System Pharmacy, 69(1), 35–39.
Wadzinski J, Franks R, Roane D and Bayard M. (2007). Valproate-associated hyperammonemic encephalopathy. The Journal of the American Board of Family Medicine, 20(5), 499–502.
Jha MK, Rahman MH and Sheikh H. (2012). Vinpocetine: a smart drug and smart nutrient: a review. International Journal of Pharmaceutical Sciences and Research, 3(2), 346-352.
Shang Y, Wang L, Li Y and Gu PF. (2016). Vinpocetine Improves Scopolamine Induced Learning and Memory Dysfunction in C57 BL/6J Mice. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin, 39(9), 1412–1418.
Gupta, S., Singh, P., Sharma, B. and Sharma, B. (2015). Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia. Current Neurovascular Research, 12(3), 240–252.
Patyar S, Prakash A, Modi M and Medhi B. (2011). Role of vinpocetine in cerebrovascular diseases. Pharmacological Reports, 63(3), 618–628.
Schlicker E, Betz R and Göthert M. (1988). Vinpocetine facilitates noradrenaline release in rat brain cortex slices. Drug Development Research, 14(3-4), 285–291.
Jeon KI, Xu X, Aizawa T, Lim JH, Jono H, Kwon DS, Abe JI, Berk BC, Li JD and Yan C. (2010). Vinpocetine inhibits NF- B-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proceedings of the National Academy of Sciences, 107(21), 9795–9800.
Molnár P and Erdő SL. (1995). Vinpocetine is as potent as phenytoin to block voltage-gated Na+ channels in rat cortical neurons. European Journal of Pharmacology, 273(3), 303–306.
Traore-Keita F, Gasquet M, Giorgio CD, Ollivier E, Delmas F, Keita A, DoumboO., Balansard G and Timon-David P. (2000). Antimalarial activity of four plants used in traditional medicine in Mali. Phytotherapy Research, 14(1), 45–47.
Udobi C and Umoh B. (2017). Effects of the ethanol extract of the stem bark of Nauclea latifolia Smith [Rubiaceae] on certain biochemical and haematological indices of Swiss Albino Mice. Asian Journal of Medicine and Health, 6(1), 1–9.
Balogun ME, Besong EE, Obu DC, Obu MSU and Djobissie SFA. (2016). Nauclea latifolia: A medicinal, economic and pharmacological review, International Journal of Plant Research, 6(2), 34-52.
Deeni Y and Hussain H. (1991). Screening for antimicrobial activity and for alkaloids of Nauclea latifolia. Journal of Ethnopharmacology, 35(1), 91–96.
Udobre AS, Etim EI, Udobang JA, Udoh AE, Akpan AE and Ekpo NA. (2013). Antiplasmodial effect of the methanol extract of the stem bark of Nauclea latifolia. Indo American Journal of Pharmaceutical Research, 3, 6484–6489.
Iyamah P and Idu M. (2015). Ethnomedicinal survey of plants used in the treatment of malaria in Southern Nigeria. Journal of Ethnopharmacology, 173, 287–302.
Abbah J, Amos S, Chindo B, Ngazal I, Vongtau H, Adzu B, Farida T, Odutola A, Wambebe C and Gamaniel K. (2010). Pharmacological evidence favouring the use of Nauclea latifolia in malaria ethnopharmacy: Effects against nociception, inflammation, and pyrexia in rats and mice. Journal of Ethnopharmacology, 127(1), 85–90.
Taïwe GS, Ngo Bum E, Talla E, Dimo T, Dawe A, Sinniger V, Bonaz, B, Boumendjel A and De Waard M. (2014). Nauclea latifolia Smith (Rubiaceae) exerts antinociceptive effects in neuropathic pain induced by chronic constriction injury of the sciatic nerve. Journal of Ethnopharmacolology, 151 (2014), 445–451
Agyare C, Spiegler V, Sarkodie H, Asase A, Liebau E and Hensel A. (2014). An ethnopharmacological survey and in vitro confirmation of the ethnopharmacological use of medicinal plants as anthelmintic remedies in the Ashanti region, in the central part of Ghana. Journal of Ethnopharmacology, 158, 255–263.
Tittikpina N, Ejike C, Estevam E, Nasim M, Griffin S, Chaimbault P, Kirsch G, Atakpama, W, Batawila K and Jacob C. (2016). Togo to go: Products and compounds derived from local plants for the treatment of diseases endemic in Sub-Saharan Africa. African Journal of Traditional, Complementary and Alternative Medicines, 13(1), 85-94.
Bum EN, Taïwe G, Moto F, Ngoupaye G Nkantchoua G, Pelanken M, Rakotonirina S and Rakotonirina A. (2009). Anticonvulsant, anxiolytic, and sedative properties of the roots of Nauclea latifolia Smith in mice. Epilepsy and Behavior, 15(4), 434–440.
Gidado A, Ameh D, Atawodi S and Ibrahim S. (2008). Hypoglycaemic activity of Nauclea latifolia sm. (Rubiaceae) in experimental animals. African Journal of Traditional Complementary and Alternative Medicines, 5(2).
Odey MO, Johnson JT, Iwara IA, Gauje B, Akpan NS, Luke UO, Robert AE and Ukpong KM. (2012). Effect of antihypertensive treatment with root and stem bark extracts of Nauclea latifolia on serum lipid profile. Global Journal of Pure and Applied Science and Technology, 2(4), 78-84.
Egwari L. (2010). Antibacterial activity of crude extracts of Nauclea latifolia and Eugenia aromatica. West African Journal of Pharmacology and Drug Research, 15(1).
Ugwu C, Ezeh I, Obitte N, Chime S and Agubata C. (2016). In vivo Anti-trypanosomal Evaluation and Phytochemical Analysis of Methanol Extract of Nauclea latifolia. British Journal of Pharmaceutical Research, 13(2), 1–9.
Owolabi O, Nworgu Z and Odushu K. (2010). Antidiarrheal evaluation of the ethanol extract of Nauclea latifolia root bark. Methods and Findings in Experimental and Clinical Pharmacology, 32(8), 551.
Evans WC, Evans D and Trease GE. (2009). Trease and Evans’ Pharmacognosy.16th ed. Edinburgh, NY: Saunders/Elsevier.
Sofowora A. (2008). Medicinal Plants and Traditional Medicine in Africa.3rd ed. Ibadan: Spectrum Books.
Niaraki MS, Nabavizadeh F, Vaezi GH, Alizadeh AM, Nahrevanian H, Moslehi A and Azizian S. (2013). Protective effect of ghrelin on sodium valproate-induced liver injury in rat. Journal Stress Physiology and Biochemistry, 9, 97 -105.
Singh B, Saxena AK, Chandan BK and Anand KK. (1998). Hepatoprotective activity of verbenalin on experimental liver damage in rodents. Fitoterapia, 69(1998), 135-140.
Sedlak J and Lindsay RH. (1968). Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal of Biochemistry, 25 (1968), 192
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG and Hoekstra WG. (1975). Selenium: biochemical role as a component of glutathione peroxidase. Science. 179(1975), 588–590.
Todorova I, Simeonova G, Kyuchukova D, Dinev D and Gadjeva V. (2005). Reference values of oxidative stress parameters (MDA, SOD, CAT) in dogs and cats. Comprehensive Clinical Pathology, 13(2005), 190 – 194.
Claiborne A (1995). Catalase activity. In: Greenwald RA, editor. Handbook of methods for oxygen radical research. Florida: CRC Press, 237–42.
Habig WH, Pabst MJ and Jakoby WB. (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biological Chemistry. 249 (1974), 7130 – 7139.
Ohkawa H, Ohishi N and Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal of Biochemistry, 95 (1979), 351–358.
Oyinbo CA, Igbigbi PS and Avwioro GO. (2016). Landolphia owariensis attenuates alcohol-induced cerebellar neurodegeneration: significance of neurofilament protein alteration in the purkinje cells. Folia Med (Plovdiv). 58 (2016), 241-249.
Oboma YI, Susan BE, Elesha SO and Jonathan M. (2017).Breast cancer biomarkers at Niger delta university hospital: Comparisons with national and international trends and clinical significance. Pathophysiology, 24 (2017), 191-196.
Chaudhary S and Parvez S. (2012) An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young rats. Neuroscience, 6, 225, 258 - 268
Pourahmad J, Eskandari MR, Kaghazi A, Shaki F, Shahraki J and Fard JK. (2012). A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis. Toxicology in Vitro, 26, 545–551
Thomaz DV, Peixoto LF, de Oliveira TS, Fajemiroye JO, da Silva Neri HF, XavierCH, Costa EA, Dos Santos FCA, de Souza Gil E and Ghedini PC. (2018). Antioxidant and Neuroprotective Properties of Eugenia dysenterica Leaves. Oxidative medicine and cellular longevity, 19(2018), 3250908
Tampellini D. (2015). Synaptic activity and Alzheimer's disease: a critical update. Frontiers in Neuroscience, 4(9), 423.
Azarnia Tehran D, Kuijpers M and Haucke V. (2018). Presynaptic endocytic factors in autophagy and neurodegeneration. Current Opinion in Neurobiology, 48, 153-159
Gabbianelli R and Damiani E. (2018). Epigenetics and neurodegeneration: role of early-life nutrition. J NutrBiochem, 57, 1-13.
Hung CH, Cheng SS, Cheung YT, Wuwongse S, Zhang NQ, Ho YS, Lee SM and Chang RC. (2018). A reciprocal relationship between reactive oxygen species and mitochondrial dynamics in neurodegeneration. Redox Biology, 14, 7-19.
Grimmig B, Kim SH, Nash K, Bickford PC and Douglas Shytle R. (2017). Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience, 39(1), 19-32.
Ferreira GC and McKenna MC.(2017). L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. Neurochemical Research 42(6), 1661-1675.
Nabavi SM, Nabavi SF, Habtemariam S, Moghaddam AH and Latifi AM.(2012). Ameliorative effects of quercetin on sodium fluoride-induced oxidative stress in rat’s kidney. Renal Failure, 34, 901–906
Zafeer MF, Waseem M, Chaudhary S and Parvez S. (2012) Cadmium-induced hepatotoxicity and its abrogation by thymoquinone. Journal of biochemical and molecular toxicology, 26, 199–205
Waseem M, Kaushik P and Parvez S. (2013). Mitochondria-mediated mitigatory role of curcumin in cisplatin-induced nephrotoxicity. Cell Biochemistry and Function, 31(8), 678–684.
Milton Prabu S, Shagirtha K and Renugadevi J. (2010) Quercetin in combination with vitamins (C and E) improves oxidative stress and renal injury in cadmium intoxicated rats. European review for medical and pharmacological sciences, 14, 903–914
Abdel-Raheem IT, Abdel-Ghany AA and Mohamed GA. (2009).Protective effect of quercetin against gentamicin-induced nephrotoxicity in rats. Biological and Pharmaceutical Bulletin, 32, 61–67
Isgrò MA, Bottoni P and Scatena R. (2015). Neuron-specific enolase as a biomarker: Biochemical and clinical aspects. Advance in Experimental Medicine and Biology, 867, 125-143
Sahu S, Nag DS, Swain A and Samaddar DP.(2017). Biochemical changes in the injured brain. World Journal of Biological Chemistry, 2017(8), 21–31.
Wijnberger LD, Nikkels PG, Van Dongen AJ, Noorlander CW and Mulder EJ.(2002). Expression In the placenta of neuronal markers for perinatal brain damage. Pediatrics Research, 51, 492- 449
Haque A, Ray SK, Cox A and Banik NL. (2016). Neuron specific enolase: A promising therapeutic target in acute spinal cord injury. Metabolic Brain Disorders 31, 487-495.
Wunderlich MT, Lins H, Skalej M, Wallesch CW and Goertler M. (2006). Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clinical Neurology and Neurosurgery, 108(6), 558 - 63.
John JS and Kevin AR. (2005).Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications. Current Drug Targets - CNS and Neurological Disorders, 4, 25-39
De Ruijter AJ, van Gennip AH, Caron HN, Kemp S and van Kuilenburg AB.(2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochemistry Journal, 370(Pt 3), 737–749.
Halili MA, Andrews MR, Sweet MJ and Fairlie DP. (2009). Histone deacetylase inhibitors ininflammatory disease. Current Topics in Medicinal Chemistry, 9(3), 309–319.
Kim HJ, Rowe M, Ren M, Hong JS, Chen PS and Chuang DM. (2007). Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. Journal of Pharmacology and Experimental Therapeutics, 321(3), 892–901.
Aung HT, Schroder K, Himes SR, Brion K, van Zuylen W, Trieu A, Suzuki H, Hayashizaki Y, Hume DA, Sweet MJ and Ravasi T. (2006). LPS regulates pro-inflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB Journal, 20(9), 1315–27.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
